The Innovative Medicines Initiative (IMI)
The AETIONOMY project is supported by the Innovative Medicines Initiative Joint Undertaking (IMI JU) under grant agreement Number 115568, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.
The AETIONOMY project is funded by the Innovative Medicines Initiative (IMI), a large-scale public- private partnership between the European Union and the pharmaceutical industry association EFPIA.
IMI aims to boost biopharmaceutical innovation in Europe and to speed up the development of better and safer medicines for patients. Through its unique and innovative funding scheme, IMI supports research projects in the areas of safety and efficacy, knowledge management and education and training.